MannKind Corp (MNKD)
4.32
0.00 (0.00%)
USD |
NASDAQ |
May 10, 16:00
4.32
0.00 (0.00%)
After-Hours: 20:00
MannKind Debt to Equity Ratio: -1.149 for March 31, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
Date | Value |
---|---|
March 31, 2024 | -1.149 |
December 31, 2023 | -1.092 |
September 30, 2023 | -1.085 |
June 30, 2023 | -1.054 |
March 31, 2023 | -1.073 |
December 31, 2022 | -1.092 |
September 30, 2022 | -1.189 |
June 30, 2022 | -1.142 |
March 31, 2022 | -1.254 |
December 31, 2021 | -1.343 |
September 30, 2021 | -1.52 |
June 30, 2021 | -1.553 |
March 31, 2021 | -1.904 |
December 31, 2020 | -0.6775 |
September 30, 2020 | -0.6535 |
June 30, 2020 | -0.6775 |
March 31, 2020 | -0.6009 |
December 31, 2019 | -0.6241 |
September 30, 2019 | -0.643 |
June 30, 2019 | -0.5101 |
March 31, 2019 | -0.5451 |
December 31, 2018 | -0.5854 |
September 30, 2018 | -0.5134 |
June 30, 2018 | -0.6261 |
March 31, 2018 | -0.6284 |
Date | Value |
---|---|
December 31, 2017 | -0.7303 |
September 30, 2017 | -0.6584 |
June 30, 2017 | -0.7449 |
March 31, 2017 | -0.7496 |
December 31, 2016 | -0.8088 |
September 30, 2016 | -0.8028 |
June 30, 2016 | -0.6072 |
March 31, 2016 | -0.5917 |
December 31, 2015 | -0.6111 |
September 30, 2015 | -1.565 |
June 30, 2015 | -2.178 |
March 31, 2015 | -2.293 |
December 31, 2014 | -3.049 |
September 30, 2014 | -5.440 |
June 30, 2014 | -4.014 |
March 31, 2014 | 9.926 |
December 31, 2013 | -8.148 |
September 30, 2013 | -2.419 |
June 30, 2013 | -2.182 |
March 31, 2013 | -2.262 |
December 31, 2012 | -2.997 |
September 30, 2012 | -1.574 |
June 30, 2012 | -1.757 |
March 31, 2012 | -1.782 |
December 31, 2011 | -1.555 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
-1.904
Minimum
Mar 2021
-0.5101
Maximum
Jun 2019
-1.042
Average
-1.088
Median
Debt to Equity Ratio Benchmarks
NovaBay Pharmaceuticals Inc | 0.3431 |
Palatin Technologies Inc | 0.00 |
iBio Inc | -- |
Theriva Biologics Inc | -- |
Oragenics Inc | -- |
Debt to Equity Ratio Related Metrics
Total Assets (Quarterly) | 480.88M |
Total Liabilities (Quarterly) | 710.85M |
Shareholders Equity (Quarterly) | -229.97M |
Current Ratio | 3.835 |
Net Debt Paydown Yield | 0.15% |